Two Sigma Investments »

Neuropace shares owned by Two Sigma Investments

Quarter-by-quarter ownership of Neuropace (NPCE) shares owned by Two Sigma Investments from 13F filings

Historical chart of Two Sigma Investments investment in Neuropace

Tip: Access up to 7 years of quarterly data

All positions including Neuropace held by Two Sigma Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neuropace by Two Sigma Investments

Quarter filed Position value Share count Share price at filing
2024-06-30 $250k 33k 7.56

More positions owned by Two Sigma Investments

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Carnival Corp Unit 99/99/9999 Put Option (CCL)
Apple Call Option (AAPL)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A (META)
Carvana Cl A (CVNA)
Snowflake Cl A (SNOW)
Bristol Myers Squibb (BMY)
Visa Com Cl A (V)
Costco Wholesale Corporation (COST)
Abbott Laboratories (ABT)
Amazon (AMZN)
Robinhood Mkts Com Cl A (HOOD)
Uber Technologies Put Option (UBER)

View all positions for Two Sigma Investments

Top funds holding Neuropace

OrbiMed Advisors
Morgan Stanley
Soleus Capital Management
Kent Lake PR
Kent Lake Capital
Vanguard Group
BlackRock
BlackRock
Nantahala Capital Management
Deutsche Bank Aktiengesellschaft
Geode Capital Management
Northern Trust
State Street Corporation
Renaissance Technologies
Charles Schwab Investment Management

View all funds holding Neuropace